Steve M Sabus Turning Point Therapeutics, Inc. (TPTX) insider trading activity

TPTX Quotes by TradingView

Steve M Sabus is SVP & Chief Commercial Officer of Turning Point Therapeutics, Inc.. Currently has a direct ownership of 0 shares of TPTX, which is worth approximately $0. The most recent transaction as insider was on Aug 17, 2022, when has been sold 36,667 shares (Common Stock) at a price of $76.0 per share, resulting in proceeds of $2,786,692. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Steve M Sabus Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 17 2022
SELL
Sale (or disposition) back to the issuer
$2,786,692 $76.0 p/Share
36,667 Reduced 100.0%
0 Common Stock
May 31 2022
BUY
Grant, award, or other acquisition
-
36,667 Added 50.0%
36,667 Common Stock

Also insider at

SNDX
Syndax Pharmaceuticals Inc Healthcare
Chief Commercial Officer
SMS

Steve M Sabus

SVP & Chief Commercial Officer
San Diego, CA

Track Institutional and Insider Activities on TPTX

Follow Turning Point Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TPTX shares.

Notify only if

Insider Trading

Get notified when an Turning Point Therapeutics, Inc. insider buys or sells TPTX shares.

Notify only if

News

Receive news related to Turning Point Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TPTX